Lipe & Dalton Increases Position in Danaher Corporation (NYSE:DHR)

Lipe & Dalton lifted its holdings in Danaher Corporation (NYSE:DHR) by 0.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,723 shares of the conglomerate’s stock after purchasing an additional 200 shares during the quarter. Danaher comprises about 2.5% of Lipe & Dalton’s portfolio, making the stock its 13th biggest position. Lipe & Dalton’s holdings in Danaher were worth $4,453,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in DHR. GHP Investment Advisors Inc. raised its holdings in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 99 shares during the period. Heck Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $27,000. Sierra Ocean LLC raised its stake in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher in the first quarter valued at $31,000. Finally, Hurley Capital LLC acquired a new stake in Danaher in the fourth quarter valued at $34,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

DHR has been the topic of several research reports. Argus dropped their price objective on Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. TD Cowen raised their price objective on shares of Danaher from $240.00 to $248.00 and gave the company a “buy” rating in a research report on Wednesday, April 23rd. UBS Group lowered their target price on shares of Danaher from $275.00 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. The Goldman Sachs Group lowered their target price on shares of Danaher from $260.00 to $240.00 and set a “neutral” rating for the company in a research note on Wednesday, April 23rd. Finally, Wells Fargo & Company lowered their target price on shares of Danaher from $240.00 to $210.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 23rd. Three equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $248.48.

Insider Transactions at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president owned 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the company’s stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman owned 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Down 1.6%

DHR stock traded down $3.04 during trading on Friday, reaching $191.75. The stock had a trading volume of 692,250 shares, compared to its average volume of 3,510,625. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $137.23 billion, a P/E ratio of 37.22, a PEG ratio of 2.71 and a beta of 0.77. The firm has a fifty day moving average price of $196.12 and a 200 day moving average price of $205.48.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. On average, equities analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.67%. Danaher’s dividend payout ratio (DPR) is presently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.